Home >> Healthcare >> Food & Beverage >>

Global Acute Coronary Syndrome (ACS) Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Published: Oct-2018 | Format: PDF | Global Info Research | Number of pages: 128 | Code: MRS - 386770

Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, crushing, central and associated with nausea and sweating. Many people with acute coronary syndromes present with symptoms other than chest pain, particularly, women, older patients, and patients with diabetes mellitus.



Scope of the Report:

This report studies the Acute Coronary Syndrome (ACS) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Acute Coronary Syndrome (ACS) market by product type and applications/end industries.

Increase in geriatric population and rise in the incidence of cardiac disorders are the major factors that drive the market growth. However, stringent government regulations for the approval of drugs are expected to restrain the market growth. Improvement in healthcare facilities in emerging regions such as Asia-Pacific and LAMEA are expected to provide new growth opportunities for the market during the analysis period.

The global Acute Coronary Syndrome (ACS) market is valued at xx million in 2017 and is expected to reach xx million by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Acute Coronary Syndrome (ACS).

Europe also play important roles in global market, with market size of xx million in 2017 and will be xx million in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

    Dexa Medica

    GlaxoSmithKline

    Novartis

    Pfizer Inc.

    Sanofi S.A.

    Serum Institute of India

    Biogen Inc.

    Eli Lilly and Company



Market Segment by Regions, regional analysis covers 

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

    Monotherapy

    Combination Therapy



Market Segment by Applications, can be divided into

    Hospitals

    Ambulatory Surgical Center

    Diagnostic Centers

Table of Contents



1 Acute Coronary Syndrome (ACS) Market Overview

    1.1 Product Overview and Scope of Acute Coronary Syndrome (ACS)

    1.2 Classification of Acute Coronary Syndrome (ACS) by Types

        1.2.1 Global Acute Coronary Syndrome (ACS) Revenue Comparison by Types (2017-2023)

        1.2.2 Global Acute Coronary Syndrome (ACS) Revenue Market Share by Types in 2017

        1.2.3 Monotherapy

        1.2.4 Combination Therapy

    1.3 Global Acute Coronary Syndrome (ACS) Market by Application

        1.3.1 Global Acute Coronary Syndrome (ACS) Market Size and Market Share Comparison by Applications (2013-2023)

        1.3.2 Hospitals

        1.3.3 Ambulatory Surgical Center

        1.3.4 Diagnostic Centers

    1.4 Global Acute Coronary Syndrome (ACS) Market by Regions

        1.4.1 Global Acute Coronary Syndrome (ACS) Market Size (Million USD) Comparison by Regions (2013-2023)

        1.4.1 North America (USA, Canada and Mexico) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

        1.4.2 Europe (Germany, France, UK, Russia and Italy) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

        1.4.4 South America (Brazil, Argentina, Colombia) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Coronary Syndrome (ACS) Status and Prospect (2013-2023)

    1.5 Global Market Size of Acute Coronary Syndrome (ACS) (2013-2023)

2 Manufacturers Profiles

    2.1 Dexa Medica

        2.1.1 Business Overview

        2.1.2 Acute Coronary Syndrome (ACS) Type and Applications

            2.1.2.1 Product A

            2.1.2.2 Product B

        2.1.3 Dexa Medica Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

    2.2 GlaxoSmithKline

        2.2.1 Business Overview

        2.2.2 Acute Coronary Syndrome (ACS) Type and Applications

            2.2.2.1 Product A

            2.2.2.2 Product B

        2.2.3 GlaxoSmithKline Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

    2.3 Novartis

        2.3.1 Business Overview

        2.3.2 Acute Coronary Syndrome (ACS) Type and Applications

            2.3.2.1 Product A

            2.3.2.2 Product B

        2.3.3 Novartis Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

    2.4 Pfizer Inc.

        2.4.1 Business Overview

        2.4.2 Acute Coronary Syndrome (ACS) Type and Applications

            2.4.2.1 Product A

            2.4.2.2 Product B

        2.4.3 Pfizer Inc. Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

    2.5 Sanofi S.A.

        2.5.1 Business Overview

        2.5.2 Acute Coronary Syndrome (ACS) Type and Applications

            2.5.2.1 Product A

            2.5.2.2 Product B

        2.5.3 Sanofi S.A. Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

    2.6 Serum Institute of India

        2.6.1 Business Overview

        2.6.2 Acute Coronary Syndrome (ACS) Type and Applications

            2.6.2.1 Product A

            2.6.2.2 Product B

        2.6.3 Serum Institute of India Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

    2.7 Biogen Inc.

        2.7.1 Business Overview

        2.7.2 Acute Coronary Syndrome (ACS) Type and Applications

            2.7.2.1 Product A

            2.7.2.2 Product B

        2.7.3 Biogen Inc. Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

    2.8 Eli Lilly and Company

        2.8.1 Business Overview

        2.8.2 Acute Coronary Syndrome (ACS) Type and Applications

            2.8.2.1 Product A

            2.8.2.2 Product B

        2.8.3 Eli Lilly and Company Acute Coronary Syndrome (ACS) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Acute Coronary Syndrome (ACS) Market Competition, by Players

    3.1 Global Acute Coronary Syndrome (ACS) Revenue and Share by Players (2013-2018)

    3.2 Market Concentration Rate

        3.2.1 Top 5 Acute Coronary Syndrome (ACS) Players Market Share

        3.2.2 Top 10 Acute Coronary Syndrome (ACS) Players Market Share

    3.3 Market Competition Trend

4 Global Acute Coronary Syndrome (ACS) Market Size by Regions

    4.1 Global Acute Coronary Syndrome (ACS) Revenue and Market Share by Regions

    4.2 North America Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    4.3 Europe Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    4.4 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    4.5 South America Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    4.6 Middle East and Africa Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

5 North America Acute Coronary Syndrome (ACS) Revenue by Countries

    5.1 North America Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

    5.2 USA Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    5.3 Canada Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    5.4 Mexico Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

6 Europe Acute Coronary Syndrome (ACS) Revenue by Countries

    6.1 Europe Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

    6.2 Germany Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    6.3 UK Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    6.4 France Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    6.5 Russia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    6.6 Italy Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue by Countries

    7.1 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

    7.2 China Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    7.3 Japan Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    7.4 Korea Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    7.5 India Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    7.6 Southeast Asia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

8 South America Acute Coronary Syndrome (ACS) Revenue by Countries

    8.1 South America Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

    8.2 Brazil Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    8.3 Argentina Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    8.4 Colombia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Acute Coronary Syndrome (ACS) by Countries

    9.1 Middle East and Africa Acute Coronary Syndrome (ACS) Revenue by Countries (2013-2018)

    9.2 Saudi Arabia Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    9.3 UAE Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    9.4 Egypt Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    9.5 Nigeria Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

    9.6 South Africa Acute Coronary Syndrome (ACS) Revenue and Growth Rate (2013-2018)

10 Global Acute Coronary Syndrome (ACS) Market Segment by Type

    10.1 Global Acute Coronary Syndrome (ACS) Revenue and Market Share by Type (2013-2018)

    10.2 Global Acute Coronary Syndrome (ACS) Market Forecast by Type (2018-2023)

    10.3 Monotherapy Revenue Growth Rate (2013-2023)

    10.4 Combination Therapy Revenue Growth Rate (2013-2023)

11 Global Acute Coronary Syndrome (ACS) Market Segment by Application

    11.1 Global Acute Coronary Syndrome (ACS) Revenue Market Share by Application (2013-2018)

    11.2 Acute Coronary Syndrome (ACS) Market Forecast by Application (2018-2023)

    11.3 Hospitals Revenue Growth (2013-2018)

    11.4 Ambulatory Surgical Center Revenue Growth (2013-2018)

    11.5 Diagnostic Centers Revenue Growth (2013-2018)

12 Global Acute Coronary Syndrome (ACS) Market Size Forecast (2018-2023)

    12.1 Global Acute Coronary Syndrome (ACS) Market Size Forecast (2018-2023)

    12.2 Global Acute Coronary Syndrome (ACS) Market Forecast by Regions (2018-2023)

    12.3 North America Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

    12.4 Europe Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

    12.5 Asia-Pacific Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

    12.6 South America Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

    12.7 Middle East and Africa Acute Coronary Syndrome (ACS) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

    14.1 Methodology

    14.2 Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)3480 View Pricing